Detecting adverse drug events with multiple representations of clinical measurements
暂无分享,去创建一个
Jing Zhao | Henrik Boström | Lars Asker | Aron Henriksson | Henrik Boström | Jing Zhao | Aron Henriksson | L. Asker
[1] Haibo He,et al. Learning from Imbalanced Data , 2009, IEEE Transactions on Knowledge and Data Engineering.
[2] Jürgen Stausberg,et al. Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data , 2011, BMC health services research.
[3] Janez Demsar,et al. Statistical Comparisons of Classifiers over Multiple Data Sets , 2006, J. Mach. Learn. Res..
[4] P. Barach,et al. Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.
[5] Sriraam Natarajan,et al. Identifying Adverse Drug Events by Relational Learning , 2012, AAAI.
[6] L. Kohn,et al. To Err Is Human : Building a Safer Health System , 2007 .
[7] Régis Beuscart,et al. Data Mining to Generate Adverse Drug Events Detection Rules , 2011, IEEE Transactions on Information Technology in Biomedicine.
[8] Bertram Pitt,et al. Withdrawal of cerivastatin from the world market , 2001, Current controlled trials in cardiovascular medicine.
[9] W. Inman,et al. Under-reporting of adverse drug reactions. , 1985, British medical journal.
[10] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[11] Miriam Sturkenboom,et al. Postmarketing Safety Surveillance , 2013, Drug Safety.
[12] S. Schroeder,et al. How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.
[13] Jing Zhao,et al. Detecting Adverse Drug Events Using Concept Hierarchies of Clinical Codes , 2014, 2014 IEEE International Conference on Healthcare Informatics.
[14] Achim Zeileis,et al. Bias in random forest variable importance measures: Illustrations, sources and a solution , 2007, BMC Bioinformatics.
[15] Jie Chen,et al. Signaling Potential Adverse Drug Reactions from Administrative Health Databases , 2010, IEEE Transactions on Knowledge and Data Engineering.
[16] Jing Zhao,et al. Predicting Adverse Drug Events by Analyzing Electronic Patient Records , 2013, AIME.
[17] Hercules Dalianis,et al. Stockholm EPR Corpus : A Clinical Database Used to Improve Health Care , 2012 .
[18] S. García,et al. An Extension on "Statistical Comparisons of Classifiers over Multiple Data Sets" for all Pairwise Comparisons , 2008 .
[19] G. Niklas Norén,et al. Opportunities and challenges of adverse drug reaction surveillance in electronic patient records , 2010 .
[20] Maria Kvist,et al. Exploration of Adverse Drug Reactions in Semantic Vector Space Models of Clinical Text , 2012, ICML 2012.
[21] N. Shah,et al. Pharmacovigilance Using Clinical Notes , 2013, Clinical pharmacology and therapeutics.
[22] M. Pirmohamed,et al. Which drugs cause preventable admissions to hospital? A systematic review. , 2007, British journal of clinical pharmacology.
[23] S. Goldman,et al. Limitations and strengths of spontaneous reports data. , 1998, Clinical therapeutics.
[24] Rich Caruana,et al. An empirical comparison of supervised learning algorithms , 2006, ICML.
[25] Barbara Sibbald,et al. Rofecoxib (Vioxx) voluntarily withdrawn from market , 2004, Canadian Medical Association Journal.
[26] Hye Jin Kam,et al. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database , 2011, Pharmacoepidemiology and drug safety.
[27] Carol Friedman,et al. Mining electronic health records for adverse drug effects using regression based methods , 2010, IHI.
[28] Henrik Druid,et al. Incidence of fatal adverse drug reactions: a population based study. , 2008, British journal of clinical pharmacology.